Abstract
The pharmacokinetics of human chorionic gonadotropin (hCG) was studied in 15 normal volunteers and 15 patients undergoing in vitro fertilization (IVF). Each subject received 6000 IU hCG, intramuscularly (im), at midcycle, and serum was assayed for hCG frequently for 16 hr. All 30 subjects achieved hCG concentrations ≥10 IU/liter within 2 hr and 19 (63%) did so within 1 hr of injection. The time taken to attain concentrations of ≥20 and ≥40 IU/liter correlated positively with the subjects' weight and/or surface area, but the correlation was not strong. Eleven of the 15 IVF patients had oocytes retrieved 34–35+hr post hCG. Three of the 11 showed evidence of prior “undetected ovulation” at the time of surgery (definite in one, presumed in two). Taking into consideration the pharmacokinetics of hCG and other factors that could lead to undetected ovulation, the authors conclude that (1) hCG is rapidly absorbed in the majority of subjects following im injection, (2) ovulation may occur earlier than 36 hr following hCG in some individuals, and (3) implementation of a shorter (than 35 hr) hCG-to-oocyte retrieval interval would be advised if undetected ovulation is to be avoided.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jagiello G, Karnicki J, Ryan RJ: Superovulation with pituitary gonadotropins: methods for obtaining meiotic metaphase figures in human ova. Lancet 1968;1:178–180
Edwards RG, Steptoe PC: Induction of follicular growth, ovulation and luteinization in the human ovary. J Reprod Fertil (Suppl) 1975;22:121–153
Wolf DP, Ochs D, Nader S, Berkowitz AS: Undetected ovulation in in vitro fertilization-embryo transfer patients. Fertil Steril 1986;46:892–896
Nader S, Berkowitz AS, Ochs D, Held B, Winkel CA: Luteal phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: Progesterone versus human chorionic gonadotropin. J Vitro Fert Embryo Transfer 1988;5:81–84
Nader S, Berowitz AS, Ochs D, Atiee S, Wolf DP, Held B: Patterns of increase in serum estradiol in response to ovarian stimulation and their relationship to oocyte fertilization and cleavage in vitro. J Vitro Fert Embryo Transfer 1987;4:307–311
Yussman MA, Taymor ML: Serum levels of follicle stimulating hormone and luteinizing hormone and of plasma progesterone related to ovulation by corpus luteum biopsy. J Clin Endocrinol 1978;30:396–398
Garcia JE, Jones GS, Wright GL: Prediction of the time of ovulation. Fertil Steril 1981;36:308–315
World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Program of Research Development and Research Training in Human Reproduction: Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17B, luteinizing hormone, follicle-stimulating hormone and progesterone. Am J Obstet Gynecol 1980;138:383–190
Testart J, Frydman R: Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil Steril 1982;37:50–53
Testart J, Frydman R, Feinstein MC, Thebault A, Roger M, Scholler R: Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: Definition of a luteinizing hormone surge-initiating rise. Fertil Steril 1981;36:50–54
Edwards RG, Steptoe PC, Purdy JM: Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynecol 1980;87:737–756
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nader, S., Berkowitz, A.S. Study of the pharmacokinetics of human chorionic gonadotropin and its relation to ovulation. J Assist Reprod Genet 7, 114–118 (1990). https://doi.org/10.1007/BF01135585
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01135585